本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
BEIJING, Jan. 15, 2026 /PRNewswire/ -- The documentary "Through Ice and Snow" (1 episode x 30 minutes), co-produced by China Review Studio and Yingda Media Investment Group Company, Ltd., will begin rolling out globally across multiple platforms starting on January 15, 2026.  documentary "Through Ice and Snow" "Through Ice and Snow" tells the story of grassroots power grid workers in the Daliang Mountains who brave the cold and snow to safeguard the energy artery of the China's west-to-east power transmission program. It showcases their wisdom, resilience, and dedication in the face of risks. The film focuses on a power grid maintenance team deep in the Daliang Mountains. Together with their new ice-clearing partner, a robot named "Bluey", they venture into the mountains to carry out de-icing operations. Thick fog, freezing temperatures, and strong winds in the mountains repeatedly challenge them, but Wei Kailin and his team grow stronger with each setback. Ultimately, they complete the task of ensuring the safety of the transmission lines, and "Bluey" becomes increasingly capable through their collaboration. However, in the unique geographical and climatic conditions of Daliang Mountains, some areas remain beyond the reach of technology. Fortunately, Wei Kailin and his team are long accustomed to traversing mountains and crossing ridges time and again, ensuring the power grid safely endures the winter. At a time when climate issues command global attention, this documentary offers a frontline perspective on energy security. It reveals the evolving synergy between technology and human effort in China's drive to overcome geographical barriers for green energy, while also painting a vivid portrait of the spirit and determination of contemporary grassroots workers in China. https://youtu.be/GON81IETzeA
MADRID, Jan. 15, 2026 /PRNewswire/ -- Future of Equestrian Sport Alliance (FESA) is pleased to announce a collaboration with Athena Hepburn, an international dressage rider competing at the highest level of the sport. Athena_Hepburn Athena A. M. Hepburn is a passionate and dedicated dressage rider and trainer with a strong foundation in natural horsemanship, specializing in the Parelli method. With extensive training under renowned professionals Luis Lucio and Juan Matute, she combines behavioral psychology and effective communication techniques to build strong, harmonious relationships with horses. Athena Hepburn recently distinguished herself on the international stage by winning the kings cup in the Grand Prix U25 and is the 2025 Madrid champion of Grand Prix. Granddaughter of the iconic Audrey Hepburn, she represents a new generation of equestrians combining sporting excellence, cultural awareness and responsible engagement. This collaboration aligns fully with FESA's mission as a Geneva-based international alliance dedicated to protecting, modernising and securing the future of equestrian sport in the face of today's challenges — including animal welfare, sustainable performance, innovation and societal expectations. A collaboration focused on the future of the sport Through this partnership, Athena Hepburn will contribute to initiatives led by FESA around high-performance sport and equine welfare, within a framework of collective action, shared responsibility and long-term vision. She is fluent in English, Spanish, Italian and German. This collaboration aims to foster a constructive approach grounded in field experience, shared expertise and a responsible vision for the future of equestrian sport. A shared vision "Athena embodies the spirit of FESA: an athlete who is committed, credible and deeply connected to the realities of the sport," said FESA."Her perspective and engagement are valuable assets in shaping the future of equestrian sport." Athena added: " I am delighted to collaborate with FESA at this pivotal moment for our sport. Contributing to a collective action in support of the future of equestrian sport and equine welfare is both a responsibility and a privilege and complements my professional life." About FESA The Future of Equestrian Sport Alliance (FESA) is an international alliance bringing together athletes, federations, scientists, universities and partners committed to ensuring the economic, social and ethical sustainability of equestrian sport — today and for generations to come. ContactJuan Carlos Capellijuan-carlos@fesa.foundation+49 1575 1127150
The rebranding signals a sharper focus on the African continent for this exclusive angel investor network SINGAPORE, Jan. 15, 2026 /PRNewswire/ -- XA Africa, the exclusive operator-led investment network founded by global technology veterans, today announced its official launch as A54. The rebrand marks a significant milestone in the network's evolution, reflecting its deepened commitment to the 54 nations of the African continent and its growing impact as a primary bridge between global expertise and local innovation. Just over one year since its public launch as XA Africa in Q4 2024, the network has rapidly established itself as a critical player in the ecosystem. To date, A54 has successfully deployed more than a quarter million US$ in capital to support the continent's most promising startups. A Proven Model for "Smart Capital" A54 distinguishes itself by moving beyond traditional venture capital. As a global community of senior leaders from the world's most prominent technology companies - including many from Google and YouTube - the network provides "smart capital" that combines funding with hands-on operational mentorship. "Our mission has always been to connect exceptional founders with the guidance they need to scale globally," said Nitin Gajria, Co-Founder of A54 and former MD of Google Sub-Saharan Africa. "As we rebrand to A54, we are doubling down on our hypothesis that operator-led investment is the most effective way to unlock Africa's profound opportunities. We aren't just investors; we are partners who have built and scaled the very products that define the modern tech landscape." Progress and Portfolio Highlights The transition to A54 follows a year of significant momentum. The network has completed 9 core investments in high-growth startups across the continent - strategically concentrated in major African tech hubs, such as Nigeria, Kenya, and South Africa. A54's early portfolio already demonstrates diverse sector backing - with notable companies including: Zeno (Kenya) PBR Life Sciences (Nigeria) BuuPass (Kenya) Kaya AI (South Africa) Talamus Health (Nigeria) Crop2Cash (Nigeria) Tix Africa (Nigeria) PowerLabs (Nigeria) Cantant (Nigeria) "Partnering with this network has been a game-changer," said Michael Ogundare, CEO of Crop2Cash. "Their strategic guidance has opened doors to new opportunities that go far beyond the initial check." Looking Ahead: The A54 Vision The name A54 represents the network's dedication to the entire African continent. In 2026, the network aims to expand its "Regional Hubs" - inclusive of both investors and VC / technology partners - in key tech centers across Africa to facilitate even more seamless investment into the region. "Africa is home to 25% of the world's youth but currently receives only 1% of global venture funding," said Marek Dawidowicz, Co-Founder of A54 and Marketing Director at YouTube. "A54 is here to change that, by proving that with the right combination of capital and global expertise African startups can lead the next wave of global innovation." Upcoming African Startup Demo Day: The A54 team will be hosting their next public [A54 Network] Startup & Investor Demo Day webinar on Thursday, March 19, 2026, at 1PM (GMT+1). This quarterly event offers an exclusive opportunity for Africa-focused investors to meet the founders of our most recent portfolio companies and learn more about the A54 investment model. Any investor or African startup ecosystem evangelist can register for the event via the A54 website or LinkedIn page. About A54: A54 is a global, operator-led investment community supporting Africa's most promising founders. Founded by veterans from the world's leading tech companies, A54 provides curated access to early-stage and growth-stage deals, combining capital with hands-on expertise to help startups scale with confidence. For more information and media queries, please visit: www.a54.network CONTACT:contact@a54.network
STOCKHOLM, Jan. 15, 2026 /PRNewswire/ -- On 30th of January, 2026, Electrolux Group will publish the results for the fourth quarter of 2025, at approx. 07.00 CET. Media, investors and analysts are invited to a simultaneous video webcast and telephone conference on the same day following the release of the results, starting at 09.00 CET where Yannick Fierling, President and CEO, together with Therese Friberg, CFO, will present the report. Information on how to join the video webcast and telephone conference is available HERE. Slides used in the presentation and report will be available at the Group's website, www.electroluxgroup.com/ir. For more information: Ann-Sofi Jönsson, Head of Investor Relations & Sustainability Reporting, +46 73 035 1005Maria Åkerhielm, Investor Relations Manager, +46 70 796 3856Henry Sjölin, Investor Relations Manager, +46 76 863 51 85Electrolux Group Press Hotline, +46 8 657 65 07 This information was brought to you by Cision http://news.cision.com https://news.cision.com/electrolux-group/r/invitation-to-presentation-of-electrolux-group-q4-report,c4291545 The following files are available for download: https://mb.cision.com/Main/1853/4291545/3873000.pdf Invitation Q4 2025
CHANGSHA, China, Jan. 15, 2026 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion"; 1157.HK) is driving a new wave of intelligent transformation by integrating AI with construction machinery, the industrial internet, big data, and cloud computing. Its full-chain AI system spans smart products, manufacturing, management, and embodied-intelligence robotics, reshaping the company into a fully digital and intelligent enterprise. Zoomlion is also scaling humanoid robotics as its "third growth curve," backed by proprietary hardware-software integration capabilities. Zoomlion's humanoid robot performs sorting tasks on the factory floor Zoomlion's full-chain AI application system covers four major pillars, namely, AI plus construction machinery, AI plus intelligent manufacturing, AI plus intelligent management, and AI plus embodied-intelligence robots. At Zoomlion Smart City, 12 smart factories and over 300 smart production lines, including 20 lights-out lines, operate as an end-to-end intelligent manufacturing system. In the AI plus intelligent manufacturing domain, processes such as cutting, welding, machining, painting, and assembly are fully connected to the industrial internet platform. This allows unified management of over 100,000 material types and intelligent manufacturing of over 400 products. AI-driven scheduling and optimization enable the park to produce an excavator every six minutes, a scissor lift every 7.5 minutes, a concrete pump truck every 27 minutes, and a truck crane every 18 minutes, marking a breakthrough in large-scale, multi-variety, small-batch agile manufacturing. Zoomlion also applies AI across R&D, production, sales, service, and supply chain management. For customer service, the Company has launched a voice-based AI expert diagnostic system with over 95 percent accuracy, enabling remote fault identification, rapid troubleshooting, and 24-hour technical support. Since 2024, Zoomlion has expanded into embodied-intelligence humanoid robotics, leveraging its full-stack self-development capabilities. Dozens of humanoid robots are now deployed in factory logistics, loading and unloading, pre-assembly, and quality inspection, forming early productivity use cases. Supported by a self-built training ground with over 100 workstations and large-scale industrial datasets, Zoomlion enables rapid iteration of human-robot collaboration. All humanoid and industrial robots are connected to the Zhongke Yungu Embodied Intelligence Platform, which integrates data, training, simulation, and OTA deployment into a closed loop, powered by a national supercomputing center with 59P GPU computing capacity and tens of thousands of distributed nodes. Beyond humanoid robotics, Zoomlion is developing a wider range of specialized robots for firefighting, mowing, construction, and agriculture. With deep integration across hardware, AI models, and real-world scenarios, the company is positioning embodied intelligence as its next major growth engine.
YONGIN, South Korea, Jan. 15, 2026 /PRNewswire/ -- GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CRO), have signed a Memorandum of Understanding (MOU) on the sidelines of the 44th Annual J.P. Morgan Healthcare Conference 2026 in San Francisco, USA, to expand their collaboration and strengthen their position in the global clinical trial market. With the rising proportion of multinational clinical trials, sponsors face varying regulatory requirements, clinical environments, and data demands across regions, driving growing demand for tailored CRO services. GCCL and OPIS will address these needs by combining their expertise to deliver integrated solutions that optimize clinical trial planning, sample analysis, and data management, offering comprehensive and customized services for biopharmaceutical companies in Europe and Asia. At the signing ceremony, representatives from both companies discussed establishing a collaborative framework across multiple areas, including joint global clinical trial services, conducting joint projects, development of new business opportunities, and additional initiatives. Through this collaboration, GCCL aims to expand strategic partnerships with global CROs and research organizations, strengthen its capability to deliver fully integrated clinical trial solutions across Asia, Europe, and the Americas, and extend tailored services to a broader range of biopharmaceutical companies. Commenting on the partnership, Giovanni Trolese, Vice President at OPIS, said, "This collaboration combines OPIS's Europe-focused global network with GCCL's clinical trial analysis expertise, creating a significant opportunity to deliver integrated and efficient clinical trial services to clients. We look forward to further expanding the global clinical trial network and continuously enhancing client-focused, innovative solutions through our close collaboration with GCCL." KwanGoo Cho, CEO of GCCL, added, "This MOU represents more than a partnership; it is a strategic collaboration to deliver optimized clinical trial solutions for global biopharmaceutical companies. By leveraging our close cooperation, we aim to maximize operational efficiency and provide tailored solutions to a diverse range of sponsors, generating tangible business synergies." About GCCL GCCL, a subsidiary of the GC Group, is a leading clinical trial sample analysis provider offering an integrated "one-stop lab solution" with central, bioanalysis, and BSL-3 labs under one system. With tailored solutions, GCCL delivers precise and efficient analytical services across all phases of clinical trials, solidifying its position as a trusted partner in new drug development. Leveraging advanced platforms and LIMS, the company supports partners across Asia and beyond with customized and compliant solutions. In recognition of its leadership, GCCL recently received Frost & Sullivan's 2025 Best Practices Customer Value Leadership Award in the Asia-Pacific clinical sample analysis services industry. For more details, visit: https://eng.gccl.co.kr/. About OPIS OPIS was founded in 1998 by medical doctors from the Pharma Industry and is a global clinical CRO with 26 years of experience in a wide range of therapeutic areas. OPIS provides full-service, 360° clinical trial support from study concept creation and protocol development to full project execution, study data handling, and up to study closure, analysis, and reporting. OPIS manages Phase I-IV, interventional, non-interventional, and medical device studies on an international level. OPIS is committed to continuous growth and expansion, and currently has affiliates in 18 countries around the world. For more details, visit: www.opisresearch.com GC Biopharma Contacts (Media) Sohee Kim shkim20@gccorp.com Yelin Jun yelin@gccorp.com Yoonjae Na yjy6520@gccorp.com GCCL Contacts (Media) HyeYeon Woo hywoo@gccorp.com
A12 藝術空間
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
